Anthony Stewart

Aug 10, 2024 | cellandgene.com | Mark Witcher |Q-Specialists AB |Irwin Hirsh |Anthony Stewart

Hello Cell & Gene readers,I'm happy to bring you July's most-clicked articles. Enjoy!Erin Harris, editor-in-chief Follow me on XJULY'S BEST FEATURED EDITORIALSystem Failure Mode & Effects Analysis: Intuitive Risk AnalysisYour company likely uses risk matrices and FMEA for analyzing risks. This article describes an alternative approach for conducting a system failure mode & effects analysis.

Jan 8, 2024 | cellandgene.com | Tim Sandle |Anthony Stewart

Cell & Gene Live welcomes Dr. Peter Marks, director, CBER, FDA, and Dr. Nicole Verdun, super office director, CBER, FDA to discuss the evolving regulatory landscape in 2024 for cell and gene therapies. Join this interactive discussion as we cover improved communication with sponsors, increased speed availability through manufacturing processes and standards development, and much more. Registration is free thanks to the support of Thermo Fisher Scientific.